Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.

被引：0
|
作者：
Hassan, R
Remaley, AT
Sampson, M
Zhang, JL
Cox, DD
Pingpank, J
Alexander, R
Willingham, M
Pastan, I
Onda, M
机构：
[1] Natl Canc Inst, Bethesda, MD USA
[2] Natl Inst Hlth, Bethesda, MD USA
[3] Wake Forest Univ, Winston Salem, NC 27109 USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9137S / 9137S
页数：1
相关论文
共 50 条
  • [21] Validation of a multi-marker panel for early detection of ovarian cancer.
    Bast, Robert C.
    Raamanathan, Archana
    Gentry-Maharaj, Aleksandra
    Skates, Steven
    Baggerly, Keith A.
    Fourkala, Rania
    Ryan, Andy
    Zhang, Zhen
    Menon, Usha
    Jacobs, Ian
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] A novel prognostic marker in ovarian cancer.
    Kyriakopoulou, LG
    Yousef, GM
    Scorilas, A
    Katsaros, D
    Massobrio, M
    Fracchioli, S
    Diamandis, EP
    CLINICAL CHEMISTRY, 2001, 47 (06) : A132 - A132
  • [23] Serum alphal-antitrypsin: A reliable tumor marker in oral cancer.
    Pramod, P. J. John
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : B233 - B233
  • [24] Detection of promoter hypermethylation of tumor suppressor genes in ovarian cancer.
    Feng, QH
    Xi, LF
    Deftereos, G
    Lu, H
    Balasubramanian, A
    Urban, N
    Drescher, C
    Kiviat, N
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1872S - 1872S
  • [25] Anti-mesothelin chimeric antigen receptor T cells in patients with epithelial ovarian cancer.
    Tanyi, Janos Laszlo
    Haas, Andrew R.
    Beatty, Gregory Lawrence
    Stashwick, Caitlin Jane
    O'Harat, Mark H.
    Morgan, Mark Aloysuis
    Porter, David L.
    Melenhorst, Jan J.
    Plesa, Gabriela
    Lacey, Simon F.
    June, Carl H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Megakaryocyte potentiation factor (MPF) is a useful tumor marker in the serum of patients with mesothelioma
    Onda, Masanori
    Nagata, Satoshi
    Ho, Mitchell
    Tapan, Bera K.
    Hassan, Raffit
    Alexander, Richard H.
    Pastan, Ira
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 635 - 636
  • [27] Serum mesothelin in epithelial ovarian carcinoma: A new screening marker and prognostic factor
    Huang, Chia-Yen
    Cheng, Wen-Fang
    Lee, Chien-Nan
    Su, Yi-Ning
    Chien, Shu-Chin
    Tzeng, Yu-Lin
    Hsieh, Chang-Yao
    Chen, Chi-An
    ANTICANCER RESEARCH, 2006, 26 (6C) : 4721 - 4728
  • [28] Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer
    Wu, Xiaohua
    Li, Dongxiu
    Liu, Liping
    Liu, Bojun
    Liang, Hongxia
    Yang, Bo
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 289 (06) : 1309 - 1314
  • [29] Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer
    Xiaohua Wu
    Dongxiu Li
    Liping Liu
    Bojun Liu
    Hongxia Liang
    Bo Yang
    Archives of Gynecology and Obstetrics, 2014, 289 : 1309 - 1314
  • [30] Changes of serum glycome in patients suffering from ovarian cancer.
    Blanchard, Veronique
    Biskup, Karina
    Braicu, Elena Ioana
    Sehouli, Jalid
    Tauber, Rudolf
    Berger, Markus
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345